SCHEMBL5777939

SCHEMBL5777939

O=[N+]([O-])c1[c]c2c([N+](=O)[O-])cccc2cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
TDP1 Q9NUW8 3/20 0.44
GPR35 Q9HC97 2/20 0.42
PDE10A Q9Y233 1/20 0.42
TSHR P16473 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NOS1 P29475 2/20 0.40
NOS2 P35228 2/20 0.40
HSD17B10 Q99714 2/20 0.40
APEX1 P27695 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
THRB P10828 1/20 0.40
HPGD P15428 1/20 0.40
NOS3 P29474 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28842041 0.74 ALDH1A1 (0.44) ALDH1A1TDP1GPR35PDE10ATSHR
SCHEMBL643696 0.74 ALDH1A1 (0.50) ALDH1A1TDP1GPR35PDE10ATSHR
SCHEMBL4320824 0.74 TDP1 (0.52) ALDH1A1TDP1GPR35TSHRSMN1; SMN2
SCHEMBL638537 0.72 ALDH1A1 (0.38) ALDH1A1TDP1TSHRSMN1; SMN2MEN1
SCHEMBL58486 0.71 TSHR (0.46) ALDH1A1TDP1GPR35TSHRSMN1; SMN2
SCHEMBL16288871 0.69 ALDH1A1 (0.48) ALDH1A1TDP1GPR35PDE10ATSHR
Pyrene SCHEMBL27684019 0.69 ALDH1A1 (0.63) ALDH1A1TDP1GPR35PDE10ATSHR
SCHEMBL6416139 0.68 S100A4 (0.41) ALDH1A1TDP1TSHRMEN1KMT2A
SCHEMBL1128345 0.68 CYP3A4 (0.43) ALDH1A1TDP1TSHRSMN1; SMN2MEN1
SCHEMBL29626558 0.68 ALDH1A1 (0.61) ALDH1A1TDP1GPR35PDE10ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060241132-A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient TORAY INDUSTRIES, INC. A CORPORATION OF JAPAN (JP) 2006-10-26 US disclosed
EP-1329451-B1 SPIRO COMPOUNDS AND ADHESION MOLECULE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT TORAY INDUSTRIES (JP) 2006-08-23 EP disclosed
US-6919349-B2 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient TORAY INDUSTRIES, INC. (JP) 2005-07-19 US disclosed
EP-1489081-A1 SPIRO DERIVATIVES AND ADHESION MOLECULE INHIBITORS COMPRISING THE SAME AS THE ACTIVE INGREDIENT TORAY INDUSTRIES, INC. (JP) 2004-12-22 EP disclosed
US-20040087574-A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient TORAY INDUSTRIES INC. (JP) 2004-05-06 US disclosed
EP-1329451-A1 SPIRO COMPOUNDS AND ADHESION MOLECULE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT TORAY INDUSTRIES, INC. (JP) 2003-07-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241132-A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient VCAM1, SELL, ICAM1 ALDH1A1 73/4885TDP1 4713/4885GPR35 2754/4885
US-20040087574-A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient VCAM1, ICAM1, SELL ALDH1A1 94/4885TDP1 4723/4885GPR35 793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.